281 related articles for article (PubMed ID: 31943002)
21. Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy.
Tan AL; Sourris KC; Harcourt BE; Thallas-Bonke V; Penfold S; Andrikopoulos S; Thomas MC; O'Brien RC; Bierhaus A; Cooper ME; Forbes JM; Coughlan MT
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F763-70. PubMed ID: 20015941
[TBL] [Abstract][Full Text] [Related]
22. A Phenyl-Pyrrolidine Derivative Reveals a Dual Inhibition Mechanism of Myocardial Mitochondrial Permeability Transition Pore, Which Is Limited by Its Myocardial Distribution.
Panel M; Ahmed-Belkacem A; Ruiz I; Guichou JF; Pawlotsky JM; Ghaleh B; Morin D
J Pharmacol Exp Ther; 2021 Mar; 376(3):348-357. PubMed ID: 33303698
[TBL] [Abstract][Full Text] [Related]
23. Pharmacologic targeting or genetic deletion of mitochondrial cyclophilin D protects from NSAID-induced small intestinal ulceration in mice.
LoGuidice A; Ramirez-Alcantara V; Proli A; Gavillet B; Boelsterli UA
Toxicol Sci; 2010 Nov; 118(1):276-85. PubMed ID: 20668000
[TBL] [Abstract][Full Text] [Related]
24. Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis.
Jobe SM; Wilson KM; Leo L; Raimondi A; Molkentin JD; Lentz SR; Di Paola J
Blood; 2008 Feb; 111(3):1257-65. PubMed ID: 17989312
[TBL] [Abstract][Full Text] [Related]
25. Phosphate is not an absolute requirement for the inhibitory effects of cyclosporin A or cyclophilin D deletion on mitochondrial permeability transition.
McGee AM; Baines CP
Biochem J; 2012 Apr; 443(1):185-91. PubMed ID: 22236255
[TBL] [Abstract][Full Text] [Related]
26. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death.
Baines CP; Kaiser RA; Purcell NH; Blair NS; Osinska H; Hambleton MA; Brunskill EW; Sayen MR; Gottlieb RA; Dorn GW; Robbins J; Molkentin JD
Nature; 2005 Mar; 434(7033):658-62. PubMed ID: 15800627
[TBL] [Abstract][Full Text] [Related]
27. Small-molecule inhibitors of cyclophilin D as potential therapeutics in mitochondria-related diseases.
Haleckova A; Benek O; Zemanová L; Dolezal R; Musilek K
Med Res Rev; 2022 Sep; 42(5):1822-1855. PubMed ID: 35575048
[TBL] [Abstract][Full Text] [Related]
28. The mitochondrial permeability transition pore regulates endothelial bioenergetics and angiogenesis.
Marcu R; Kotha S; Zhi Z; Qin W; Neeley CK; Wang RK; Zheng Y; Hawkins BJ
Circ Res; 2015 Apr; 116(8):1336-45. PubMed ID: 25722455
[TBL] [Abstract][Full Text] [Related]
29. CypD deficiency confers neuroprotection against mitochondrial abnormality caused by lead in SH-SY5Y cell.
Ye F; Li X; Liu Y; Jiang A; Li X; Yang L; Chang W; Yuan J; Chen J
Toxicol Lett; 2020 May; 323():25-34. PubMed ID: 31874198
[TBL] [Abstract][Full Text] [Related]
30. The Mitochondrial Permeability Transition Pore Regulator Cyclophilin D Exhibits Tissue-Specific Control of Metabolic Homeostasis.
Laker RC; Taddeo EP; Akhtar YN; Zhang M; Hoehn KL; Yan Z
PLoS One; 2016; 11(12):e0167910. PubMed ID: 28005946
[TBL] [Abstract][Full Text] [Related]
31. Cyclophilin D Knock-Out Mice Show Enhanced Resistance to Osteoporosis and to Metabolic Changes Observed in Aging Bone.
Shum LC; White NS; Nadtochiy SM; Bentley KL; Brookes PS; Jonason JH; Eliseev RA
PLoS One; 2016; 11(5):e0155709. PubMed ID: 27183225
[TBL] [Abstract][Full Text] [Related]
32. Discovery of non-peptidic small molecule inhibitors of cyclophilin D as neuroprotective agents in Aβ-induced mitochondrial dysfunction.
Park I; Londhe AM; Lim JW; Park BG; Jung SY; Lee JY; Lim SM; No KT; Lee J; Pae AN
J Comput Aided Mol Des; 2017 Oct; 31(10):929-941. PubMed ID: 28913661
[TBL] [Abstract][Full Text] [Related]
33. Oxidative stress alters mitochondrial bioenergetics and modifies pancreatic cell death independently of cyclophilin D, resulting in an apoptosis-to-necrosis shift.
Armstrong JA; Cash NJ; Ouyang Y; Morton JC; Chvanov M; Latawiec D; Awais M; Tepikin AV; Sutton R; Criddle DN
J Biol Chem; 2018 May; 293(21):8032-8047. PubMed ID: 29626097
[TBL] [Abstract][Full Text] [Related]
34. p53-cyclophilin D mediates renal tubular cell apoptosis in ischemia-reperfusion-induced acute kidney injury.
Yang H; Li R; Zhang L; Zhang S; Dong W; Chen Y; Wang W; Li C; Ye Z; Zhao X; Li Z; Wu Y; Zhang M; Liu S; Dong Z; Liang X
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1311-F1317. PubMed ID: 31339772
[TBL] [Abstract][Full Text] [Related]
35. Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple Sclerosis.
Warne J; Pryce G; Hill JM; Shi X; Lennerås F; Puentes F; Kip M; Hilditch L; Walker P; Simone MI; Chan AW; Towers GJ; Coker AR; Duchen MR; Szabadkai G; Baker D; Selwood DL
J Biol Chem; 2016 Feb; 291(9):4356-73. PubMed ID: 26679998
[TBL] [Abstract][Full Text] [Related]
36. Estrogen receptor beta modulates permeability transition in brain mitochondria.
Burstein SR; Kim HJ; Fels JA; Qian L; Zhang S; Zhou P; Starkov AA; Iadecola C; Manfredi G
Biochim Biophys Acta Bioenerg; 2018 Jun; 1859(6):423-433. PubMed ID: 29550215
[TBL] [Abstract][Full Text] [Related]
37. Liver cyclophilin D deficiency inhibits the progression of early NASH by ameliorating steatosis and inflammation.
Li X; Yang M; Sun H; Ferdous MRU; Gao L; Zhao J; Song Y
Biochem Biophys Res Commun; 2022 Feb; 594():168-176. PubMed ID: 35085894
[TBL] [Abstract][Full Text] [Related]
38. Cyclophilin D participates in the inhibitory effect of high-fat diet on the expression of steroidogenic acute regulatory protein.
Su X; Lin D; Luo D; Sun M; Wang X; Ye J; Zhang M; Zhang Y; Xu X; Yu C; Guan Q
J Cell Mol Med; 2019 Oct; 23(10):6859-6871. PubMed ID: 31373170
[TBL] [Abstract][Full Text] [Related]
39. Restoring mitochondrial superoxide levels with elamipretide (MTP-131) protects
Miyamoto S; Zhang G; Hall D; Oates PJ; Maity S; Madesh M; Han X; Sharma K
J Biol Chem; 2020 May; 295(21):7249-7260. PubMed ID: 32277051
[TBL] [Abstract][Full Text] [Related]
40. Targeted deletion of nicotinamide adenine dinucleotide phosphate oxidase 4 from proximal tubules is dispensable for diabetic kidney disease development.
Thallas-Bonke V; Tan SM; Lindblom RS; Snelson M; Granata C; Jha JC; Sourris KC; Laskowski A; Watson A; Tauc M; Rubera I; Zheng G; Shah AM; Harris DCH; Elbatreek MH; Kantharidis P; Cooper ME; Jandeleit-Dahm K; Coughlan MT
Nephrol Dial Transplant; 2021 May; 36(6):988-997. PubMed ID: 33367789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
